Oaktree Acquisition Corp. III Life Sciences’ (NASDAQ:OACCU – Get Free Report) quiet period is set to expire on Tuesday, December 3rd. Oaktree Acquisition Corp. III Life Sciences had issued 17,500,000 shares in its public offering on October 24th. The total size of the offering was $175,000,000 based on an initial share price of $10.00. During the company’s quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
Oaktree Acquisition Corp. III Life Sciences Price Performance
NASDAQ:OACCU opened at $10.10 on Monday. Oaktree Acquisition Corp. III Life Sciences has a fifty-two week low of $9.99 and a fifty-two week high of $10.22.
Featured Stories
- Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Stock Sentiment Analysis: How it Works
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
